IP Library Granted Patent US 11,396,656
Granted Patent B2
US 11,396,656 · App. 16/877,401 · Granted Jul 26, 2022

Nucleic acid encoding n-methylputrescine oxidase and uses thereof

Inventors: Jonathan E. Page (Saskatoon, CA); Enwu Liu (Saskatoon, CA)
Assignee: 22nd Century Limited, LLC
C12N15/8243A24B13/00A24B15/12C12N9/0022C12Y104/03006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,396,656
App. No.
16/877,401
Granted
Jul 26, 2022
Kind
B2
Abstract

The gene encoding N-methylputrescine oxidase (MPO) and constructs comprising such DNA are provided, including methods of regulating MPO expression independently or with other alkaloid biosynthesis genes to modulate alkaloid production in plants and host cells. MPO genes or fragments thereof are useful for reducing pyrrolidine or tropane alkaloid production in plants, for increasing pyrrolidine or tropane alkaloid production in plants, and for producing an MPO enzyme in host cells.

Claims (48)

1. A method for reducing an alkaloid in a plant comprising down-regulating N-methylputrescine oxidase (MPO) expression of an endogenous MPO gene as compared to a control plant, wherein the method comprises:

(a) introducing into the plant a nucleic acid comprising:

(i) at least one of an RNAi plasmid or a virus-induced gene silencing vector; and

(ii) a nucleotide sequence selected from the group consisting of:

(1) nucleotides 754-1132 of SEQ ID NO: 1;

(2) nucleotides 1521-1772 of SEQ ID NO: 1;

(3) nucleotides 1129-1405 of SEQ ID NO: 1;

(4) SEQ ID NO: 1; and

(5) SEQ ID NO: 2; and

(b) growing the plant under conditions whereby the nucleotide sequence is transcribed, and whereby the transcription results in decreased levels of alkaloid in the plant as compared to a control plant grown under similar conditions.

2. The method of claim 1 , further comprising down-regulating at least one of NBB1, A622, QPT, and PMT.

3. The method of claim 1 , wherein the alkaloid is pyrrolidine alkaloid.

4. The method of claim 3 , wherein the pyrrolidine alkaloid is nicotine.

5. The method of claim 1 , wherein the plant is Nicotiana tabacum.

6. A reduced alkaloid plant produced by the method of claim 1 .

7. A reduced alkaloid product produced from the plant of claim 6 .

8. The reduced alkaloid product of claim 7 , wherein the product is selected from the group consisting of smoking cessation products, cigarettes, cigarette tobacco, cigars, cigar tobacco, pipe tobacco, chewing tobacco, snus, tobacco lozenges, food products, food ingredients, feed products, feed ingredients, nutritional supplements, and biofuels.

9. A method for down-regulating N-methylputrescine oxidase expression in a plant as compared to a control plant comprising:

(a) introducing into the plant a nucleic acid comprising:

(i) at least one of an RNAi plasmid or a virus-induced gene silencing vector; and;

(ii) a nucleotide sequence selected from the group consisting of:

(1) nucleotides 754-1132 of SEQ ID NO: 1;

(2) nucleotides 1521-1772 of SEQ ID NO: 1;

(3) nucleotides 1129-1405 of SEQ ID NO: 1;

(4) SEQ ID NO: 1; and

(5) SEQ ID NO: 2; and

(b) growing the plant under conditions whereby the nucleotide sequence is transcribed, and whereby the transcription results in decreased levels of N-methylputrescine oxidase in the plant as compared to a control plant grown under similar conditions.

10. The method of claim 9 , wherein the plant belongs to the genus Nicotiana.

11. The method of claim 10 , wherein the plant is Nicotiana tabacum.

12. The method of claim 9 , further comprising down-regulating at least one of NBB1, A622, QPT, and PMT.

13. An isolated host plant cell genetically engineered to have reduced N-methylputrescine oxidase levels comprising:

(a) an RNAi plasmid comprising at least one of the following:

(i) nucleotides 754-1132 of SEQ ID NO: 1;

(ii) nucleotides 1521-1772 of SEQ ID NO: 1;

(iii) nucleotides 1129-1405 of SEQ ID NO: 1;

(iv) SEQ ID NO: 1; or

(v) SEQ ID NO: 2; or

(b) a virus-induced gene silencing vector comprising at least one of the following:

(i) nucleotides 754-1132 of SEQ ID NO: 1;

(ii) nucleotides 1521-1772 of SEQ ID NO: 1;

(iii) nucleotides 1129-1405 of SEQ ID NO: 1;

(iv) SEQ ID NO: 1; or

(v) SEQ ID NO: 2;

wherein the sequence of (i)-(v) is in either sense, antisense, or inverted repeat orientation.

14. The isolated cell of claim 13 , wherein the cell is a cell of a plant from a member of family Solanaceae or family Erythroxylaceae.

15. The isolated cell of claim 13 , wherein the cell is a cell of a plant from a member of genus Nicotiana, Datura, Atropa, Duboisia, Hyoscyamus, Mandragora, Brugmansia, Scopolia or Erythroxylon.

16. The isolated cell of claim 13 , wherein the cell is a cell of a plant from a member of the Nicotiana genus.

17. The isolated cell of claim 13 , wherein the cell is a cell of a plant of the species Nicotiana tabacum.

Assignments (2)
PATENT SECURITY AGREEMENT Recorded Mar 29, 2023
From: 22ND CENTURY GROUP, INC.
To: JGB COLLATERAL, LLC
Reel/Frame 063188/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 19, 2021
From: NATIONAL RESEARCH COUNCIL OF CANADA
To: 22ND CENTURY LIMITED, LLC
Reel/Frame 055657/0887 →